Vaccine #008 / MENINGOCOCCAL DISEASE

#008 of an ongoing series called Crypto Vaccines. --- MenioVax is indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135. MenioVax is approved for use in individuals 9 months through 55 years of age. EFFECTIVENESS: 71 - 95% TYPE: Recombinant Vaccine NUMBER OF SHOTS: 2 HOW GIVEN: Intramuscularly AGE: 9 months through 55 years of age STORAGE TEMPERATURE: 2° to 8°C --- CRYPTO VACCINES LABORATORIES